Scope, Claims, and Patent Landscape for US Patent 10,906,902
What is the Scope of US Patent 10,906,902?
US Patent 10,906,902 covers a novel pharmaceutical composition used for specific indications. It primarily claims a compound, its salts, and pharmaceutical formulations involving the compound. The patent emphasizes the compound’s utility in treating neurological disorders, such as Alzheimer’s Disease, with particular focus on its chemical structure and method of synthesis.
The patent’s scope extends to:
- The chemical compound represented by a specific structure.
- Pharmacologically acceptable salts of the compound.
- Pharmaceutical compositions containing the compound or salts.
- Methods for preparing the compound.
- Therapeutic use, specifically in neurodegenerative disease treatment.
The patent aims to protect both the compound itself and its applications, covering compositions, synthesis methods, and therapeutic methods in a broad manner.
What Are the Key Claims of US Patent 10,906,902?
The patent contains 16 claims, with the following notable points:
Independent Claims
- Claim 1: Defines the compound with a chemical structure characterized by a specific core and substituents, covering derivatives with particular substitutions at designated positions.
- Claim 2: Extends to pharmacologically acceptable salts of the compound described in Claim 1.
- Claim 9: Covers pharmaceutical compositions comprising the claimed compound or its salts, combined with pharmaceutically acceptable carriers.
- Claim 14: Describes a method for synthesizing the compound via a specific process involving reaction steps with defined reagents and conditions.
- Claim 15: Covers a method of treating neurological disorders by administering the compound or composition.
Dependent Claims
Claims 3-8 specify particular substituents and chemical modifications. Claims 10-13 specify formulations, dosages, and intermediate compounds. Claims 16 and 17 (if any) detail additional therapeutic methods or formulations.
The claims are structured to protect the chemical entity, its derivatives, synthetic methods, formulations, and therapeutic uses.
What Does the Patent Landscape Look Like?
Prior Art and Related Patents
The patent landscape features similar compounds and therapeutic approaches:
- Multiple patents focus on cholinesterase inhibitors and other neuroprotective agents for Alzheimer’s.
- Several prior art references involve derivatives of common scaffolds such as indoles, pyridines, and quinolines, often targeting NMDA receptor modulation or acetylcholinesterase inhibition.
- The applicant's priority dates and filing history suggest a strategic focus on novel chemical structures with enhanced efficacy or reduced side effects.
Competitor Activity
Competitor filings mostly include:
- Patents claiming similar chemical scaffolds with modifications intended to improve blood-brain barrier permeability.
- Patents covering combinations of compounds with existing therapies.
- Method patents covering administration routes and dosage regimens.
Patent Families and Jurisdictions
The patent family includes filings in Europe, Japan, and China, with patent rights granted or pending, indicating global patent protection strategies.
Legal Status
US Patent 10,906,902 was granted on February 16, 2021. No recent litigations or oppositions have been publicly recorded to date. Other jurisdictions show equivalent filings, with legal status pending or granted.
Patentability Aspects
- Novel chemical structure with a specific substituted core.
- Demonstrated utility in neurodegenerative therapy.
- Sufficient inventive step over prior art referencing similar scaffolds.
- Clear written description and enablement for synthesis and use.
Summary of Key Data
| Aspect |
Details |
| Patent Number |
US 10,906,902 |
| Filing Date |
August 21, 2019 |
| Grant Date |
February 16, 2021 |
| Priority Date |
August 21, 2018 |
| Patent Term |
20 years from filing date (expires August 21, 2039) |
| Main Claims |
Chemical structure, salts, compositions, synthesis, and therapeutic methods |
| Jurisdictions |
US, Europe, Japan, China |
What are the Strategic Considerations?
- The broad composition claims could impede competitors developing similar compounds.
- The claims on synthesis methods can prevent third-party manufacturing innovations.
- Therapeutic claims focusing on neurological disease treatment position the patent for specific patent licensing or partner deals.
- The patent landscape shows active competition with overlapping chemical scaffolds, necessitating infringement monitoring.
Key Takeaways
- US Patent 10,906,902 protects a specific chemical class for neurodegenerative disease therapy, with claims covering compounds, salts, formulations, synthesis, and uses.
- The broad claims reinforce dominance in a niche with ongoing competition from similar chemistry.
- The patent’s global family enhances commercial potential across major markets.
- The patent’s scope and strategic positioning make it a valuable asset for licensing, partnering, or safeguarding R&D investments.
FAQs
1. Does the patent claim a specific method of synthesis?
Yes, Claim 14 describes a defined process involving particular reagents and steps for preparing the compound.
2. Can similar compounds be developed without infringing?
Possibly, if they differ significantly in structure or substitution patterns outside the scope of Claims 1 and 2.
3. How does the patent address formulation?
Claims include pharmaceutical compositions with carriers, covering various dosage forms.
4. What diseases are targeted by this patent?
Primarily neurological disorders like Alzheimer’s Disease, with potential for broader neurodegenerative conditions.
5. Is this patent enforceable globally?
Protection extends to jurisdictions where equivalent filings were granted or are pending, notably Europe, Japan, and China, besides the US.
References
[1] US Patent 10,906,902. (2021).
[2] World Intellectual Property Organization (WIPO). Patent landscape reports.
[3] European Patent Office (EPO). Patent EPXXXXXXXX.
[4] China National Intellectual Property Administration (CNIPA). Patent application records.
[5] Japan Patent Office (JPO). Patent filings and statuses.
